IRulya Therapeutics, Inc. (IRLA)
31.00
+1.69
(+5.77%)
USD |
NASDAQ |
Nov 06, 16:00
30.85
-0.15
(-0.48%)
After-Hours: 20:00
IRulya Therapeutics EPS Diluted (TTM) : -125.60 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -125.60 |
| March 31, 2026 | -182.05 |
| December 31, 2025 | -260.54 |
| September 30, 2025 | -175.70 |
| June 30, 2025 | -126.00 |
| March 31, 2025 | -57.89 |
| December 31, 2024 | -57.81 |
| September 30, 2024 | -1.247 |
| June 30, 2024 | -1.268 |
| March 31, 2024 | -0.7606 |
| December 31, 2023 | -0.8432 |
| September 30, 2023 | -0.7792 |
| June 30, 2023 | -0.8533 |
| March 31, 2023 | -1.228 |
| December 31, 2022 | -1.604 |
| September 30, 2022 | -2.232 |
| Date | Value |
|---|---|
| June 30, 2022 | -2.739 |
| March 31, 2022 | -2.964 |
| December 31, 2021 | -3.027 |
| September 30, 2021 | -2.941 |
| June 30, 2021 | -2.941 |
| March 31, 2021 | -2.804 |
| December 31, 2020 | -2.631 |
| September 30, 2020 | -2.396 |
| June 30, 2020 | -2.034 |
| March 31, 2020 | -2.008 |
| December 31, 2019 | -1.611 |
| September 30, 2019 | -24.31 |
| June 30, 2019 | -24.07 |
| March 31, 2019 | -23.50 |
| June 30, 2018 | -23.28 |
| March 31, 2018 | -0.1258 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Korsana Biosciences, Inc. | -11.76 |
| PepGen Inc. | -1.306 |
| Q32 Bio, Inc. | 3.343 |
| Bridgebio Oncology Therapeutics, Inc. | -1232.83 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |